Lily Hu
DualityBio Inc.
8
0
0
N/A
0
3
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+11 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (8)
Research Network
Collaboration Network
Research Areas & Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Rahul Aggarwal, MD
University of California, San Francisco
Shared therapeutic areas:
shun lu, MD
Shanghai Chest Hospital
Shared therapeutic areas:
lin shen
Peking University Cancer Hospital & Institute
Shared therapeutic areas:
Jane Robertson
AstraZeneca
Shared therapeutic areas:
Steven A Rosenberg, M.D.
National Cancer Institute (NCI)
Shared therapeutic areas:
Jane Robertson, BSc, MBCHB, MD
AstraZeneca
Shared therapeutic areas:
You Lu, MD
West China Hospital
Shared therapeutic areas:
Javier Martín Broto
Hospital Universitario Fundación Jiménez Díaz
Shared therapeutic areas:
Soo Chin Lee
National University Hospital, Singapore
Shared therapeutic areas:
Sriram Yennu
M.D. Anderson Cancer Center
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (8)
Showing 8 of 8 trials
A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
All 8 trials loaded